Genetic determinants of 'cognitive impairment, no dementia'

Journal of Alzheimer's Disease

Volumn 33, Issue 3, 2013, Pages 831-840

  Dubé, Joseph B ^a   Johansen, Christopher T ^a   Robinson, John F ^a   Lindsay, Joan ^b   Hachinski, Vladimir ^c   Hegele, Robert A ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Alzheimer's disease; APOE; cardiovascular diseases; genome wide association study; mild cognitive impairment; vascular dementia

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84872468342     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121477     Document Type: Article

References (40)

1. American Psychiatric Association. Task Force on DSM-IV (1994) Diagnostic and statistical manual of mental disorders: DSM-IV, American Psychiatric Association, Washington, D.C.
2. Geldmacher DS, Whitehouse PJ (1996) Evaluation of dementia. N Engl J Med 335, 330-336.
3. Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, Schipper HM, Blair M, Kertesz A, Chertkow H (2008) Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ 178, 825-836.
4. Burns A, Iliffe S (2009) Dementia. BMJ 338, b75.
5. Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, Inzitari D (2007) CIND and MCI in the Italian elderly: Frequency, vascular risk factors, progression to dementia. Neurology 68, 1909-1916. (Pubitemid 46848623)
6. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I (1997) Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349, 1793-1796. (Pubitemid 27257555)
7. Tuokko HA, Frerichs RJ, Kristjansson B (2001) Cognitive impairment, no dementia: Concepts and issues. Int Psychogeriatr 13(Supp 1), 183-202. (Pubitemid 34171233)
8. Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, Drolet V, Kirk J, Freedman M, Bergman H (2008) Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 178, 1273-1285. (Pubitemid 351678349)
9. Tuokko H, Frerichs R, Graham J, Rockwood K, Kristjansson B, Fisk J, Bergman H, Kozma A, McDowell I (2003) Fiveyear follow-up of cognitive impairment with no dementia. Arch Neurol 60, 577-582. (Pubitemid 36427972)
10. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222.
11. Holtzman DM, Herz J, Bu G (2012) Apolipoprotein e and apolipoprotein e receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2, a006312.
12. Cechetto DF, Hachinski V, Whitehead SN (2008) Vascular risk factors and Alzheimer's disease. Expert Rev Neurother 8, 743-750. (Pubitemid 351656825)
13. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association. Stroke 42, 2672-2713.
14. Wolf PA(2012) Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch Neurol 69, 567-571.
15. Kalaria RN (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21, 321-330. (Pubitemid 30387091)
16. Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA (2004) APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology 63, 1399-1402. (Pubitemid 39426271)
17. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D,Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H,Warden D,Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43, 429-435.
18. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43, 436-441.
19. Hegele RA (2009) Plasma lipoproteins: Genetic influences and clinical implications. Nat Rev Genet 10, 109-121.
20. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, FeitosaMF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, Guo X, Li M, Shin Cho Y, Jin Go M, Jin Kim Y, Lee JY, Park T, Kim K, Sim X, Twee-Hee Ong R, Croteau-Chonka DC, Lange LA, Smith JD, Song K, Hua Zhao J, Yuan X, Luan J, Lamina C, Ziegler A, Zhang W, Zee RY, Wright AF, Witteman JC, Wilson JF. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713.
21. Hirschhorn JN, Daly MJ (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6, 95-108. (Pubitemid 40179532)
22. (1994) Canadian study of health and aging: Study methods and prevalence of dementia. CMAJ 150, 899-913.
23. Teng EL, Chui HC (1987) The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48, 314-318. (Pubitemid 17138128)
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575. (Pubitemid 47330214)
25. (2003) The International HapMap Project. Nature 426, 789-796.
26. Ge D, Zhang K, Need AC, Martin O, Fellay J, Urban TJ, Telenti A, Goldstein DB (2008) WGAViewer: Software for genomic annotation of whole genome association studies. Genome Res 18, 640-643. (Pubitemid 351482788)
27. Bertram L, McQueen M, Mullin K, Blacker D, Tanzi RE, The AlzGene Database, Alzheimer Research Forum, http://www.alzgene.org, Posted 18 April 2011, Accessed 27 April 2012.
28. Dupont WD, Plummer WD Jr (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19, 589-601. (Pubitemid 29057724)
29. Hsiung GY, Sadovnick AD, Feldman H (2004) Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: Data from the Canadian Study of Health and Aging. CMAJ 171, 863-867. (Pubitemid 39371553)
30. Feldman HH, Jacova C (2005) Mild cognitive impairment. Am J Geriatr Psychiatry 13, 645-655. (Pubitemid 41197235)
31. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
32. Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ (2011) Predictive value of APOE-Epsilon4 allele for progression from MCI to AD-type dementia: A meta-analysis. J Neurol Neurosurg Psychiatry 82, 1149-1156.
33. Bergem AL, Engedal K, Kringlen E (1997) The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch Gen Psychiatry 54, 264-270. (Pubitemid 27132055)
34. Schrijvers EM, Schurmann B, Koudstaal PJ, van den Bussche H, Van Duijn CM, Hentschel F, Heun R, Hofman A, Jessen F, Kolsch H, Kornhuber J, Peters O, Rivadeneira F, Ruther E, Uitterlinden AG, Riedel-Heller S, Dichgans M, Wiltfang J, Maier W, Breteler MM, Ikram MA (2011) Genome-wide association study of vascular dementia. Stroke 43, 315-319.
35. Speliotes EK,Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Allen HL, Lindgren CM, Luan J, Magi R, Randall JC, Vedantam S, Winkler TW, Qi L, Workalemahu T, Heid IM, Steinthorsdottir V, Stringham HM, Weedon MN, Wheeler E, Wood AR, Ferreira T, Weyant RJ, Segre AV, Estrada K, Liang L, Nemesh J, Park JH, Gustafsson S, Kilpelainen TO, Yang J, Bouatia-Naji N, Esko T, Feitosa MF, Kutalik Z, Mangino M, Raychaudhuri S, Scherag A, Smith AV, Welch R, Zhao JH, Aben KK, Absher DM, Amin N, Dixon AL, Fisher E, Glazer NL, Goddard ME, Heard-Costa NL (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42, 937-948.
36. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT, Colantuoni EA, Elkahloun AG, Herman MM, Weinberger DR, Kleinman JE (2011)Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519-523.
37. Harbison ST, Yamamoto AH, Fanara JJ, Norga KK, Mackay TF(2004) Quantitative trait loci affecting starvation resistance in Drosophila melanogaster. Genetics 166, 1807-1823. (Pubitemid 38621062)
38. Wagner SA, Beli P,Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C (2011) A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics 10, M111.013284.
39. Tarawneh R, Holtzman DM (2012) The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med 2, a006148.
40. Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197-2204. (Pubitemid 350294674)